DYN•benzinga•
JP Morgan Maintains Neutral on Dyne Therapeutics, Lowers Price Target to $17
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 21, 2025 by benzinga